Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma

In this commentary on Wang, Wu, Xia, and colleagues, Clinical Translational Medicine, 2022, we sum up and discuss recent evidence on the regulation and relevance of the transcription factor c‐FOS in diffuse large B cell lymphoma cells that are treated with epigenetic erasers of the histone deacetyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Krämer, Oliver H., Schneider, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126358/
https://www.ncbi.nlm.nih.gov/pubmed/35604882
http://dx.doi.org/10.1002/ctm2.858
_version_ 1784712110255636480
author Krämer, Oliver H.
Schneider, Günter
author_facet Krämer, Oliver H.
Schneider, Günter
author_sort Krämer, Oliver H.
collection PubMed
description In this commentary on Wang, Wu, Xia, and colleagues, Clinical Translational Medicine, 2022, we sum up and discuss recent evidence on the regulation and relevance of the transcription factor c‐FOS in diffuse large B cell lymphoma cells that are treated with epigenetic erasers of the histone deacetylase inhibitor family.
format Online
Article
Text
id pubmed-9126358
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91263582022-05-25 Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma Krämer, Oliver H. Schneider, Günter Clin Transl Med Commentary In this commentary on Wang, Wu, Xia, and colleagues, Clinical Translational Medicine, 2022, we sum up and discuss recent evidence on the regulation and relevance of the transcription factor c‐FOS in diffuse large B cell lymphoma cells that are treated with epigenetic erasers of the histone deacetylase inhibitor family. John Wiley and Sons Inc. 2022-05-23 /pmc/articles/PMC9126358/ /pubmed/35604882 http://dx.doi.org/10.1002/ctm2.858 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Krämer, Oliver H.
Schneider, Günter
Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title_full Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title_fullStr Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title_full_unstemmed Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title_short Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
title_sort single‐cell profiling guided combination therapy of c‐fos and histone deacetylase inhibitors in diffuse large b‐cell lymphoma
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126358/
https://www.ncbi.nlm.nih.gov/pubmed/35604882
http://dx.doi.org/10.1002/ctm2.858
work_keys_str_mv AT krameroliverh singlecellprofilingguidedcombinationtherapyofcfosandhistonedeacetylaseinhibitorsindiffuselargebcelllymphoma
AT schneidergunter singlecellprofilingguidedcombinationtherapyofcfosandhistonedeacetylaseinhibitorsindiffuselargebcelllymphoma

Ejemplares similares